Familial hypercholesterolaemia trials in Australia
7 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleA Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
- Where
- Clayton, Nedlands
- Age
- 6 years to 17 years
- People
- 153 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07058077 · EU 2024-519068-42-00 - Phase 1/2Not yet taking people in AustraliaEDIT-401 in Adults Who Require Additional Lowering of Low-Density Lipoprotein Cholesterol (LDL-C)
- Where
- Charlestown, Perth
- Age
- 18 years to 65 years
- People
- 56
- Run by
- Editas Medicine, Inc.
See details and how to joinNCT07894887 - Phase 1Taking peoplePhase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
- Where
- Adelaide, Melbourne
- Age
- 18 years to 70 years
- People
- 132 worldwide
- Run by
- Verve Therapeutics, Inc.
See details and how to joinNCT06451770 · EU 2025-522617-39-00 - No phaseTaking peopleGuideline Oriented Approach To Lipid Lowering In Asia-Pacific
- Where
- Bedford Park, Cairns, Clayton, Melbourne, Wollongong
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- Stephen Nicholls
See details and how to joinNCT05325034 - Phase 1Taking peopleA Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
- Where
- Clayton
- Age
- 18 years to 70 years
- People
- 64 worldwide
- Run by
- Monash University
See details and how to joinNCT07428473 - Phase 1Taking peopleA Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
- Where
- Adelaide, Brisbane, Camperdown, Heidelberg, Melbourne
- Age
- 18 years to 75 years
- People
- 90 worldwide
- Run by
- CRISPR Therapeutics AG
See details and how to joinNCT07491172 - Phase 1Taking peopleA Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
- Where
- Adelaide, Melbourne, Sydney
- Age
- 18 years to 70 years
- People
- 85 worldwide
- Run by
- Verve Therapeutics, Inc.
See details and how to joinNCT06164730